Noncanonical Wnt5a supports prostate cancer dormancy in the bone microenvironment via its cognate receptor Ror2 and induction of downstream Siah E3 Ubiquitin Protein Ligase 2 (SIAH2) (Ren et al., 2019). Here, SIAH2 is linked to prostate cancer.